Lupin Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Lupin Ltd with 125 companies shown from the same industry classification, including Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | 92,483 Cr. | 2,030 | 2,530/1,900 | 15.5 | 491 | 0.89 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 95,904 Cr. | 1,672 | 1,740/1,066 | 25.4 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,073 Cr. | 1,233 | 1,415/1,080 | 32.0 | 454 | 0.65 % | 13.0 % | 11.2 % | 1.00 |
| Mankind Pharma Ltd | 1,03,418 Cr. | 2,504 | 2,642/1,910 | 45.7 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Laurus Labs Ltd | 1,06,626 Cr. | 1,980 | 2,055/838 | 122 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Cipla Ltd | 1,08,448 Cr. | 1,346 | 1,673/1,166 | 30.3 | 426 | 0.97 % | 15.5 % | 11.6 % | 2.00 |
| Glenmark Life Sciences Ltd | 67,170 Cr. | 2,335 | 2,538/1,793 | 21.5 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 67,170 Cr. | 2,335 | 2,538/1,793 | 21.5 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Alkem Laboratories Ltd | 61,898 Cr. | 5,164 | 5,934/5,051 | 27.2 | 1,156 | 1.03 % | 21.2 % | 18.9 % | 2.00 |
| Biocon Ltd | 60,188 Cr. | 370 | 447/338 | 82.8 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Abbott India Ltd | 57,648 Cr. | 27,125 | 30,655/25,135 | 35.7 | 2,247 | 1.94 % | 44.8 % | 34.4 % | 10.0 |
| Ipca Laboratories Ltd | 48,779 Cr. | 1,927 | 2,039/1,252 | 35.5 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 47,861 Cr. | 2,899 | 3,042/1,574 | 33.9 | 656 | 0.69 % | 17.4 % | 12.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 46,856 Cr. | 2,769 | 3,121/2,088 | 44.5 | 134 | 2.06 % | 61.4 % | 45.6 % | 10.0 |
| Ajanta Pharma Ltd | 45,239 Cr. | 3,621 | 3,797/2,379 | 39.9 | 362 | 0.88 % | 34.5 % | 27.1 % | 2.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,603 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Wockhardt Ltd | 34,327 Cr. | 2,116 | 2,422/1,087 | 86.1 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| Neuland Laboratories Ltd | 27,365 Cr. | 21,350 | 24,235/11,500 | 55.0 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Acutaas Chemicals Ltd | 26,860 Cr. | 3,279 | 3,740/1,290 | 69.6 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Granules India Ltd | 23,067 Cr. | 847 | 924/520 | 35.5 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Caplin Point Laboratories Ltd | 20,652 Cr. | 2,716 | 2,991/1,500 | 31.0 | 443 | 0.29 % | 24.2 % | 20.9 % | 2.00 |
| Shilpa Medicare Ltd | 20,465 Cr. | 1,047 | 1,076/260 | 72.0 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Pfizer Ltd | 17,722 Cr. | 3,875 | 5,578/3,831 | 23.0 | 919 | 1.94 % | 24.1 % | 18.0 % | 10.0 |
| Cohance Lifesciences Ltd | 17,030 Cr. | 444 | 918/267 | 158 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| ERIS Lifesciences Ltd | 16,548 Cr. | 1,192 | 1,740/1,180 | 25.2 | 282 | 0.60 % | 14.1 % | 18.7 % | 1.00 |
| Jubilant Pharmova Ltd | 16,365 Cr. | 1,029 | 1,185/784 | 42.2 | 445 | 0.49 % | 8.99 % | 6.53 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 16,253 Cr. | 825 | 998/635 | 21.8 | 289 | 1.45 % | 12.6 % | 13.4 % | 2.00 |
| Astrazeneca Pharma India Ltd | 15,465 Cr. | 6,186 | 9,850/6,120 | 89.2 | 349 | 0.58 % | 29.3 % | 23.3 % | 2.00 |
| Natco Pharma Ltd | 14,806 Cr. | 828 | 1,227/792 | 12.9 | 515 | 0.60 % | 17.4 % | 17.1 % | 2.00 |
| Marksans Pharma Ltd | 14,603 Cr. | 322 | 351/155 | 28.3 | 66.7 | 0.28 % | 18.8 % | 15.2 % | 1.00 |
| Concord Biotech Ltd | 14,378 Cr. | 1,374 | 1,668/987 | 50.6 | 193 | 0.55 % | 17.4 % | 12.6 % | 1.00 |
| Blue Jet Healthcare Ltd | 10,172 Cr. | 538 | 693/325 | 43.3 | 78.4 | 0.22 % | 26.1 % | 19.4 % | 2.00 |
| Procter & Gamble Health Ltd | 9,201 Cr. | 5,563 | 6,975/4,700 | 27.6 | 316 | 2.79 % | 83.9 % | 61.9 % | 10.0 |
| Suven Life Sciences Ltd | 9,032 Cr. | 320 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Aarti Pharmalabs Ltd | 8,644 Cr. | 954 | 1,002/584 | 40.2 | 234 | 0.37 % | 10.7 % | 8.59 % | 5.00 |
| Entero Healthcare Solutions Ltd | 7,420 Cr. | 1,709 | 1,920/944 | 57.5 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,393 Cr. | 694 | 745/118 | 53.7 | 113 | 0.22 % | 16.9 % | 11.8 % | 1.00 |
| Sanofi India Ltd | 7,043 Cr. | 3,057 | 4,898/3,049 | 20.6 | 359 | 2.45 % | 57.5 % | 43.0 % | 10.0 |
| Morepen Laboratories Ltd | 6,904 Cr. | 126 | 128/33.0 | 58.8 | 22.8 | 0.16 % | 8.05 % | 5.33 % | 2.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 6,081 Cr. | 207 | 219/67.1 | 34.4 | 61.3 | 0.48 % | 11.3 % | 8.42 % | 2.00 |
| Orchid Pharma Ltd | 5,990 Cr. | 997 | 1,144/471 | 332 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| FDC Ltd | 5,526 Cr. | 339 | 476/313 | 17.9 | 153 | 1.47 % | 15.4 % | 11.2 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 5,071 Cr. | 388 | 479/225 | 104 | 26.4 | 0.17 % | 18.1 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 5,022 Cr. | 3,037 | 3,130/1,731 | 43.0 | 366 | 0.79 % | 25.7 % | 19.3 % | 8.00 |
| Zota Health Care Ltd | 4,484 Cr. | 1,295 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 4,471 Cr. | 477 | 494/241 | 49.4 | 85.9 | 0.08 % | 12.9 % | 11.9 % | 1.00 |
| Gufic BioSciences Ltd | 4,317 Cr. | 432 | 468/268 | 58.7 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Aarti Drugs Limited | 3,910 Cr. | 431 | 534/319 | 22.6 | 154 | 0.46 % | 11.7 % | 12.7 % | 10.0 |
| Unichem Laboratories Ltd | 3,847 Cr. | 546 | 687/278 | 31.5 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 3,776 Cr. | 3,641 | 3,949/829 | 46.3 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,521 Cr. | 725 | 774/422 | 825 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,376 Cr. | 389 | 425/87.0 | 51.9 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,81,791 Cr. | 4,800 | 5,250/3,480 | 81.5 | 248 | 0.79 % | 15.2 % | 27.4 % | 5.00 |
| Advanced Enzyme Technologies Ltd | 3,149 Cr. | 282 | 420/252 | 20.0 | 146 | 1.90 % | 14.0 % | 10.2 % | 2.00 |
| Hikal Ltd | 2,686 Cr. | 218 | 261/146 | 63.4 | 97.2 | 0.28 % | 3.50 % | 2.21 % | 2.00 |
| Dishman Carbogen Amcis Ltd | 2,472 Cr. | 157 | 307/128 | 136 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Indoco Remedies Ltd | 2,417 Cr. | 262 | 317/162 | 102 | 0.08 % | 0.96 % | 9.36 % | 2.00 | |
| Venus Remedies Ltd | 2,400 Cr. | 1,796 | 2,044/432 | 20.7 | 497 | 0.56 % | 20.7 % | 15.6 % | 10.0 |
| Syncom Formulations (India) Ltd | 2,345 Cr. | 25.1 | 27.5/10.2 | 27.6 | 4.39 | 0.40 % | 24.8 % | 17.6 % | 1.00 |
| Fredun Pharmaceuticals Ltd | 2,315 Cr. | 1,404 | 1,600/427 | 52.1 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Beta Drugs Ltd | 2,276 Cr. | 2,053 | 2,808/990 | 49.9 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Panacea Biotec Ltd | 2,231 Cr. | 366 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Hester Biosciences Ltd | 1,856 Cr. | 2,176 | 2,684/1,239 | 35.0 | 423 | 0.51 % | 15.2 % | 15.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,624 Cr. | 550 | 580/249 | 29.7 | 138 | 0.68 % | 20.6 % | 16.4 % | 5.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,566 Cr. | 238 | 265/155 | 33.3 | 41.2 | 1.68 % | 22.7 % | 17.3 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,486 Cr. | 515 | 760/476 | 23.9 | 128 | 0.95 % | 24.8 % | 18.4 % | 1.00 |
| TTK Healthcare Ltd | 1,442 Cr. | 1,023 | 1,250/735 | 18.8 | 789 | 0.98 % | 8.04 % | 6.30 % | 10.0 |
| Kopran Ltd | 1,347 Cr. | 278 | 296/107 | 53.9 | 110 | 1.08 % | 6.65 % | 4.91 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,169 Cr. | 586 | 770/440 | 12.1 | 378 | 0.31 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,070 Cr. | 116 | 147/65.0 | 43.3 | 0.43 % | 2.74 % | 0.41 % | 1.00 | |
| Anuh Pharma Ltd | 878 Cr. | 87.4 | 99.5/66.7 | 19.9 | 35.1 | 1.72 % | 14.9 % | 10.7 % | 5.00 |
| Bafna Pharmaceuticals Ltd | 864 Cr. | 371 | 378/94.8 | 111 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Kilitch Drugs (India) Ltd | 733 Cr. | 213 | 234/117 | 24.4 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Wanbury Ltd | 697 Cr. | 200 | 360/162 | 16.2 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Albert David Ltd | 497 Cr. | 872 | 932/580 | 22.0 | 686 | 0.57 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 318 Cr. | 103 | 104/50.3 | 76.3 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| Lyka Labs Ltd | 301 Cr. | 83.2 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| BDH Industries Ltd | 285 Cr. | 495 | 610/340 | 24.4 | 134 | 1.01 % | 20.5 % | 14.8 % | 10.0 |
| Gennex Laboratories Ltd | 242 Cr. | 9.95 | 17.2/7.05 | 12.8 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Everest Organics Ltd | 221 Cr. | 222 | 536/197 | 42.0 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Nectar Lifescience Ltd | 204 Cr. | 10.5 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Coral Laboratories Ltd | 203 Cr. | 568 | 679/360 | 10.7 | 585 | 0.35 % | 11.0 % | 7.79 % | 10.0 |
| Bal Pharma Ltd | 175 Cr. | 110 | 125/59.7 | 24.3 | 51.6 | 1.10 % | 9.69 % | 7.87 % | 10.0 |
| Brooks Laboratories Ltd | 161 Cr. | 55.8 | 138/36.3 | 12.2 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Par Drugs & Chemicals Ltd | 156 Cr. | 127 | 180/78.0 | 10.8 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Auro Laboratories Ltd | 153 Cr. | 245 | 317/159 | 31.9 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Achyut Healthcare Ltd | 146 Cr. | 6.03 | 10.0/4.70 | 455 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Gujarat Inject (Kerala) Ltd | 138 Cr. | 9.40 | 14.3/1.96 | 45.9 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Godavari Drugs Ltd | 132 Cr. | 121 | 135/69.7 | 33.8 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Alpa Laboratories Ltd | 124 Cr. | 59.5 | 99.8/46.0 | 28.3 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 124 Cr. | 60.2 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Vaishali Pharma Ltd | 109 Cr. | 8.35 | 11.9/4.75 | 25.7 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Pharmaids Pharmaceuticals Ltd | 104 Cr. | 29.4 | 60.8/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Concord Drugs Ltd | 98.2 Cr. | 74.5 | 92.5/61.0 | 48.1 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 94.1 Cr. | 67.8 | 97.4/56.1 | 11.8 | 66.0 | 3.69 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 72.6 Cr. | 14.5 | 26.0/13.0 | 19.9 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 60.0 Cr. | 24.0 | 24.0/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| ANG Lifesciences India Ltd | 53.5 Cr. | 41.0 | 49.7/17.6 | 47.6 | 0.00 % | 0.95 % | 7.33 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 49.0 Cr. | 30.4 | 46.8/25.6 | 102 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| Mangalam Drugs and Organics Ltd | 48.6 Cr. | 30.7 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Vivimed Labs Ltd | 45.9 Cr. | 5.44 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Bharat Immunological & Biological Corporation Ltd | 39.1 Cr. | 9.06 | 22.6/8.62 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.55/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bacil Pharma Ltd | 37.4 Cr. | 26.1 | 61.8/10.6 | 57.6 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 37.3 Cr. | 49.4 | 53.0/29.7 | 12.2 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 28.1 Cr. | 36.1 | 59.8/29.0 | 12.7 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Checkpoint Trends Ltd | 17.2 Cr. | 31.5 | 144/28.4 | 14.0 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Beryl Drugs Ltd | 13.0 Cr. | 25.6 | 27.6/15.9 | 21.0 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 12.2 Cr. | 81.2 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Dipna Pharmachem Ltd | 11.5 Cr. | 4.36 | 25.0/3.90 | 4.36 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Colinz Laboratories Ltd | 9.66 Cr. | 76.7 | 87.9/36.1 | 19.3 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Adline Chem Lab Ltd | 8.80 Cr. | 15.0 | 17.1/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Brawn Biotech Ltd | 7.08 Cr. | 23.6 | 24.4/17.7 | 8.32 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Decipher Labs Ltd | 6.06 Cr. | 6.00 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.36 Cr. | 0.81 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Evoq Remedies Ltd | 3.81 Cr. | 1.53 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| Industry Average | 17,658.11 Cr | 1,260.22 | 55.31 | 211.60 | 0.38% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Lupin Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Lupin Ltd analysis · Explore all Pharmaceuticals stocks